AR087497A1 - Producto veterinario para el tratamiento de la mastitis, pre-composiciones antibiotica y antiinflamatoria, kit, metodo de preparacion, uso y metodo de tratamiento de la mastitis - Google Patents

Producto veterinario para el tratamiento de la mastitis, pre-composiciones antibiotica y antiinflamatoria, kit, metodo de preparacion, uso y metodo de tratamiento de la mastitis

Info

Publication number
AR087497A1
AR087497A1 ARP120102910A ARP120102910A AR087497A1 AR 087497 A1 AR087497 A1 AR 087497A1 AR P120102910 A ARP120102910 A AR P120102910A AR P120102910 A ARP120102910 A AR P120102910A AR 087497 A1 AR087497 A1 AR 087497A1
Authority
AR
Argentina
Prior art keywords
mastitis
treatment
antibiotic
veterinary product
inflammatory
Prior art date
Application number
ARP120102910A
Other languages
English (en)
Inventor
Maurizio Billi
Original Assignee
Eurofarma Lab S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurofarma Lab S A filed Critical Eurofarma Lab S A
Publication of AR087497A1 publication Critical patent/AR087497A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Reivindicación 1: Producto veterinario para el tratamiento de la mastitis, caracterizado por estar constituido por una mezcla de una pre-composición antibiótica que comprende por lo menos un antibiótico y excipientes farmacéuticamente aceptables y una pre-composición antiinflamatoria que comprende por lo menos un antiinflamatorio y excipientes farmacéuticamente aceptables.Reivindicación 2: Producto veterinario, de acuerdo con la reivindicación 1, caracterizado porque dicho antibiótico es sulfato de neomicina. Reivindicación 3: Producto veterinario, de acuerdo con la reivindicación 1, caracterizado porque dicho antibiótico es adipato de espiramicina. Reivindicación 4: Producto veterinario, de acuerdo con la reivindicación 1, caracterizado porque dicho antiinflamatorio es flumetasona.
ARP120102910A 2011-08-19 2012-08-09 Producto veterinario para el tratamiento de la mastitis, pre-composiciones antibiotica y antiinflamatoria, kit, metodo de preparacion, uso y metodo de tratamiento de la mastitis AR087497A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI1103782-2A BRPI1103782A2 (pt) 2011-08-19 2011-08-19 produto veterinÁrio para tratamento de mastite, pre composiÇço antibiàtica a anti inflamatària, kit, mÉtodo de preparaÇço uso e mÉtodo de tratamento de mastite

Publications (1)

Publication Number Publication Date
AR087497A1 true AR087497A1 (es) 2014-03-26

Family

ID=47745789

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120102910A AR087497A1 (es) 2011-08-19 2012-08-09 Producto veterinario para el tratamiento de la mastitis, pre-composiciones antibiotica y antiinflamatoria, kit, metodo de preparacion, uso y metodo de tratamiento de la mastitis

Country Status (4)

Country Link
AR (1) AR087497A1 (es)
BR (1) BRPI1103782A2 (es)
UY (1) UY34270A (es)
WO (1) WO2013026119A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003269311A1 (en) * 2002-10-08 2004-05-04 Ancare New Zealand Ltd. Antibiotic formulation for intramammary administration in milking animals
US20050004098A1 (en) * 2003-03-20 2005-01-06 Britten Nancy Jean Dispersible formulation of an anti-inflammatory agent
US20040214753A1 (en) * 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
KR100707988B1 (ko) * 2006-04-12 2007-04-16 경북대학교 산학협력단 젖소 유방염 치료 및 예방을 위한 복합항생제 조성물
RU2432943C1 (ru) * 2010-10-19 2011-11-10 Закрытое акционерное общество Научно-производственное предприятие "Агрофарм" Препарат для лечения мастита у коров в период лактации

Also Published As

Publication number Publication date
UY34270A (es) 2013-04-05
BRPI1103782A2 (pt) 2013-07-30
WO2013026119A1 (pt) 2013-02-28

Similar Documents

Publication Publication Date Title
ES2582284T3 (es) Composición que comprende microbiota intestinal humana anaeróbicamente cultivada
ES2540751T3 (es) Composición para mejorar la función sexual masculina que contiene extracto de baya de ginseng
CU20140068A7 (es) Triazolopiridinas sustituidas
CL2009000902A1 (es) Composicion que comprende posaconazol disuelto o disperso molecularmente en un polimero derivado de hidroxipropilcelulosa; formulacion farmaceutica que comprende a la composion; un proceso para preparar a la composicion mediante fusioextrusion; y su uso para tratar una infeccion micotica.
CU20120171A7 (es) Triazolopiridinas sustituidas
CO2017001035A2 (es) “2-(morfolin-4-il)-1,7-naftiridinas sustituidas, composiciones y combinaciones farmacéuticas que las comprenden, y compuestos intermediarios
CL2015003117A1 (es) Modificaciones en la estructura cristalina
GT201500053A (es) Composicion farmaceutica recubierta que contiene regorafenib
CL2008000510A1 (es) Compuestos conjugados farmaco-ligandos, que se unen a citotoxinas potentes; composicion farmaceutica; y uso para retardar o detener el crecimiento de un tumor en un mamifero.
CL2014000370A1 (es) Hemifumarato de tenofovir alafenamida; metodo de preparación; composicion farmaceutica que lo comprende; metodo para preparar la composicion farmaceutica; y uso en el tratamiento de una infeccion por hiv.
ECSP11011278A (es) Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente.
ECSP12012310A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
CO6720961A2 (es) Imidazopiridazinas sustituidas
GT201500105A (es) Imidazo [1,2-a] piridincarboxamidas aminosustituidas y su uso
CU20130069A7 (es) Derivados de 2,3-dihidroimidazo[1,2-c] quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermeddes asociadas a la angiogénesis
ECSP13013011A (es) Triazolopiridinas
CL2013002869A1 (es) Una combinacion que contiene 2-amino-n-[7-metoxi-8-(3-morfolin-4-ilpropoxi)-2,3-dihidroimidazo[1,2-c]quinazolin-5-il]pirimidin-5-carboxamida y abt-737; y su uso para el tratamiento o profilaxis de cancer de mama, en particular cáncer de mama inflamatorio, cancer de mama triple negativo, cancer de mama positivo a receptor de her2 y cancer de mama positivo a receptor de hormona.
PE20151759A1 (es) Imidazopiridazinas sustituidas
UY35693A (es) Pirazolo[1,5-a]piridin-3-carboxamidas sustituidas y su uso
UY35298A (es) Formulación en dispersión sólida de un compuesto antiviral
ECSP088889A (es) Forma nueva de administración de racecadotril
PE20160048A1 (es) Composiciones antibioticas de ceftolozano
GT201200304A (es) Composiciones farmacéuticas que comprenden hidromorfona y naloxona
BR112013024606A2 (pt) composição, kit farmacêutico, e, métodos para o tratamento de uma condição de pele, e para preparar uma composição
BR112014031706A8 (pt) Composições farmacêuticas orais, e composição farmacêutica oral compreendendo itraconazol

Legal Events

Date Code Title Description
FA Abandonment or withdrawal